News stories about Anthem (NYSE:ANTM) have trended somewhat positive on Saturday, according to Accern Sentiment. The research firm ranks the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Anthem earned a coverage optimism score of 0.12 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.3945423024956 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
These are some of the media stories that may have impacted Accern Sentiment Analysis’s scoring:
- Primed for Breakout or Bust? A look at Anthem, Inc. (NYSE:ANTM) and CNOOC Limited (NYSE:CEO) – FLBC News (flbcnews.com)
- Reviewing Aetna (AET) & Anthem (ANTM) (americanbankingnews.com)
- UnitedHealth Appoints New CEO, Hemsley Takes On New Role (finance.yahoo.com)
- Myriad Genetics (MYGN) EndoPredict Secures Positive Coverage Decisions from Medicare & Anthem (ANTM) – StreetInsider.com (streetinsider.com)
- Anthem, Inc. (ANTM) Given New $201.00 Price Target at Morgan Stanley (americanbankingnews.com)
Several brokerages have recently weighed in on ANTM. Cantor Fitzgerald reissued a “buy” rating and issued a $136.00 price objective on shares of Anthem in a research report on Thursday, May 11th. Morgan Stanley began coverage on shares of Anthem in a research report on Tuesday, June 6th. They set an “equal weight” rating and a $196.00 price target on the stock. Bank of America Corporation raised their price target on shares of Anthem from $224.00 to $228.00 and gave the stock a “buy” rating in a research report on Friday, July 14th. Deutsche Bank AG raised their price target on shares of Anthem from $173.00 to $185.00 and gave the stock a “hold” rating in a research report on Thursday, July 13th. Finally, Citigroup Inc. reaffirmed a “buy” rating and set a $205.00 price target on shares of Anthem in a research report on Wednesday, June 28th. Eleven investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $181.76.
Shares of Anthem (ANTM) traded down 0.49% on Friday, reaching $191.02. 1,061,167 shares of the company were exchanged. The stock’s 50-day moving average is $190.39 and its 200 day moving average is $177.46. Anthem has a 12-month low of $114.85 and a 12-month high of $194.94. The firm has a market capitalization of $50.16 billion, a PE ratio of 18.06 and a beta of 0.73.
Anthem (NYSE:ANTM) last released its quarterly earnings results on Wednesday, July 26th. The company reported $3.37 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.23 by $0.14. The firm had revenue of $22.20 billion during the quarter, compared to analyst estimates of $22.25 billion. Anthem had a return on equity of 12.93% and a net margin of 3.24%. The business’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same period in the previous year, the company posted $3.33 EPS. On average, analysts forecast that Anthem will post $11.82 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Monday, September 25th. Stockholders of record on Friday, September 8th will be given a $0.70 dividend. This represents a $2.80 annualized dividend and a dividend yield of 1.47%. This is a positive change from Anthem’s previous quarterly dividend of $0.65. The ex-dividend date is Thursday, September 7th. Anthem’s payout ratio is presently 24.62%.
In related news, Director Julie A. Hill sold 555 shares of the company’s stock in a transaction dated Wednesday, May 24th. The stock was sold at an average price of $180.56, for a total transaction of $100,210.80. Following the transaction, the director now directly owns 37,448 shares of the company’s stock, valued at approximately $6,761,610.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Julie A. Hill sold 524 shares of the company’s stock in a transaction dated Thursday, August 10th. The shares were sold at an average price of $190.80, for a total value of $99,979.20. Following the transaction, the director now directly owns 36,924 shares in the company, valued at $7,045,099.20. The disclosure for this sale can be found here. Over the last three months, insiders sold 13,754 shares of company stock valued at $2,595,073. Corporate insiders own 0.36% of the company’s stock.
Anthem Company Profile
Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.
Receive News & Ratings for Anthem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.